Experts pinpoint number of hours of sleep that could raise risk of dementia
It's well known that not getting enough sleep can increase dementia risk, but scientists have now discovered that too much shut eye could be just as harmful.
Researchers have found that sleeping an average of nine hours a night can fuel brain ageing that lead to memory problems in later life.
The study, by scientists at the University of Texas Health Science Centre, found that this amount of sleep added an average of six and a half years to the age of participants' brains.
Commenting on the findings they concluded that 'long sleep duration' could be 'an early and potentially reversible' risk factor for the memory-robbing disease.
The study followed 1,853 healthy adults aged 27-85, and studied how their sleep duration affected cognitive abilities.
The participants' cognitive function was assessed every four years using gold standard measurements of memory, verbal reasoning, visual-spatial awareness and reaction times.
Participants also completed a survey every four years, detailing the number of hours they typically slept each night.
Results showed that, on average, those who slept for nine or more hours per night over the course of the two decade study performed significantly worse in all four cognitive tests.
Scientists found the poorest results were seen in people who showed depressive symptoms, and had nine or more hours sleep a night, on average.
The mood disorder is known to trigger patterns of excessive sleep, and the experts pose that depression, rather than sleep itself, may be driving the cognitive decline in these patients.
However, its not just those who suffer from low mood that are at risk from too much rest.
Participants who showed no signs of depression, but slept for more than nine hours a night, experienced decreased cognitive function, struggling with global cognition and visual reproduction.
'Disturbances in sleep duration and patterns contribute to an increased risk of cognitive deficits and Alzheimer's disease', Prof Young explained.
The most recent findings echo that of previous studies, including one 10-year-long report, published in the Psychiatry Research journal, that found sleeping for more than eight hours a night, on average, was linked with an alarming 64 per cent increased risk of dementia.
Whilst experts are not entirely sure why excess shut eye could contribute to dementia, one Swedish study suggested the explanation may lie with the impact on our circadian rhythms—the natural sleep-wake cycles that determine a host of bodily functions.
The experts from the Karolinska Institutet in Stockholm argued that being asleep during the daytime could impact the brain's ability to clear waste that builds up during the day.
But the scientists said it is also possible that brain damage caused by early dementia could be fueling a need for excess sleep.
It comes as a landmark study last year suggested almost half of all cases of Alzheimer's disease—the most common cause of dementia—could be prevented by tackling 14 lifestyle factors.
These included hearing loss, high cholesterol, vision loss and lack of exercise.
Experts claimed the study, published in the prestigious journal The Lancet, provided more hope than 'ever before' that the disorder that blights the lives of millions can be prevented.
Alzheimer's Disease affects 982,000 people in the UK.
Alzheimer's Research UK analysis found 74,261 people died from dementia in 2022 compared with 69,178 a year earlier, making it the country's biggest killer.
One 2019 estimate put the annual death toll at 70,000 people a year with the health issues caused costing the NHS £700million each year to treat.
The WHO puts the annual global death toll from physical inactivity at around 2million per year, making it in the running to be among the top 10 leading causes of global death and disability.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
an hour ago
- Daily Mail
EXCLUSIVE UFC fighter loved by Donald Trump reveals 'miracle' $1 weight loss drug helped her cut 30lbs
UFC Champion Kayla Harrison revealed she used Zyn nicotine pouches to help with her brutal 30-pound weight cut. The $1 pouches have been hugely popular among young people and TikTokers for their appetite suppressing effects. But they've since entered the mainstream, capturing the attention of athletes and politicians. Harrison, 34, credited Zyn pouches with helping her cut down from 165lbs to 135lbs for her championship fight at the weekend. She secured the world title this weekend after tapping out her opponent, before wrapping the belt around President Donald Trump's waist in a viral photo. Harrison, who has historically struggled with weight cutting, has been vocal about her grueling regimen, which includes six miles of biking, running and swimming a day and eating only foods made by a professional chef. But days after her victory, the mixed martial artist revealed it wasn't just cardio or dieting that won her the title. She wrote on X: 'Shoutout to @zyn for getting me to 135. I'm not sponsored but I wanna be.' Zyn is a brand of tiny nicotine pouches no larger than a thumbnail that has emerged as an unlikely weight loss secret weapon. It's well known that nicotine suppresses your appetite by sending satiety signals to receptors in the brain, convincing your brain that you don't need to eat. It also ramps up your heart rate and sends in a flood of adrenaline, which activates the body's 'fight or flight' response. In this state, the body doesn't want food. For this reason, cigarettes have long been linked to weight loss, but the risks of lung cancer and heart attacks far outweighs the benefits. The same thing happens with Zyn, but the science is much murkier. After being inserted between the lips and gum, Zyn releases nicotine into the bloodstream slowly, with effects lasting up to an hour, compared to just minutes for cigarettes. This could stave off hunger for much longer than smoking. Experts told that while the $1 pouch can ward off hunger, it still contains highly addictive nicotine, which attacks arteries and increases the risks of heart attacks and stroke. It's also been shown to lead to gum disease and oral cancers, which are on the rise in the US and UK. Tucker Carlson launched his own brand of nicotine pouches called Alp. Health secretary Robert F Kennedy Jr was also seen popping what looked like a Zyn during his confirmation hearings. The FDA approved Zyn as a smoking alternative earlier this year, citing evidence it would help wean smokers off traditional tobacco. So far, 10 flavors have been approved in the US, including coffee, cinnamon and menthol. However, the pouches have been available for over a decade, leading young people to boast improvements to their fitness, energy and sexual performance. Gen Z has also dubbed them 'O-Zyn-pic,' a reference to it being a significantly cheaper Ozempic alternative for weight loss. A pack of 15 Zyn pouches sells for $5-$10, whereas Ozempic can run up to $1,000 a month without insurance. The nicotine in Zyn is thought to activate the α3β4 receptors in the brain, which send signals promoting fullness, even if a user is actually hungry. It may also increase the production of leptin, a satiety hormone, and boost the body's ability to burn fat. There's little evidence on the long-term effects of Zyn, but the risks of nicotine have been well documented. Dr Hector Perez, lead bariatric surgeon at Renew Bariatrics, told 'I think it's safe to say that using Zyn as a weight loss drug is like using a chainsaw to slice bread. Yes, Zyn contains nicotine, and yes, nicotine is a known appetite suppressant. 'But let's be clear: using Zyn or any nicotine product as a weight loss tool is not safe, sustainable, or smart. To lose 30 pounds in a few months with nicotine as the main strategy would likely require near-constant dosing, and that's a chemical crutch verging on addiction, not simply hunger control.' Though Zyn doesn't contain tobacco, it still has highly addictive nicotine. Roughly 24million Americans over 12, nine percent of the population, are dependent on nicotine. Nicotine addiction leads to withdrawal symptoms like irritability, cravings, restless legs, anxiety and trouble sleeping. The adrenaline rush caused by nicotine also increases heart rate and blood pressure as part of the body's 'fight-or-flight' response. While this gives users a burst of excitement, repeated stress on the cardiovascular system makes the heart have to work harder to pump blood. The weaker the heart and its surrounding arteries get, the more likely they are to become blocked, leading to a heart attack. Nicotine also attacks the lungs and reduces their function, which could prove detrimental for elite athletes like Harrison. Dr Perez said: 'Zyn is the Wild West. You're playing with your heart rate, blood pressure, and potentially your long-term brain chemistry.' Nicotine may also lead to lasting dental issues. Dr Pia Lieb, cosmetic dentist at Cosmetic Dentistry Center in New York City, told 'Using [Zyn] more long term, users are putting themselves at risk of developing gum disease, as nicotine is a vasoconstricter.' This means is reduces blood flow to the gums, leading to swelling and bleeding. 'This can lead to gum recession, which can expose the roots of teeth, making them more vulnerable to decay and sensitivity,' Dr Lieb added. She also warns nicotine is still a carcinogen linked to oral cancers, which strike 60,000 Americans a year and kill 13,000.
Daily Mail
an hour ago
- Daily Mail
Doctor who has performed hundreds of autopsies reveals how people 'unknowingly' die of cancer
In 2025, it is predicted that more than 600,000 people will die of cancer in the United States - but within that is a small number who don't even know they have it. While many of these people are treated after their cancer is detected, a pathologist has revealed that he has come across several who unknowingly passed away from the deadly disease. Dr. Wolfe, who has performed numerous autopsies to determine people's cause of death, recently posted a shocking TikTok sharing three stories from within the last few months. In the video, he explained that whilst it is not common, he has performed several autopsies on people - of all different ages - finding their cause of death is not what medics originally thought. The doctor began by discussing how one man had complained of a chronic cough before he died which he had blamed on his smoking. 'He finally gets so severe, where he can't stop coughing. Now, he's coughing up blood, he gets taken to the ER and they do imaging and he has a complete white out on his lungs,' he explained. 'He then codes and dies,' he continued. 'He comes to the autopsy table and I find he does have a horrible pneumonia - one of the worst pneumonias I've ever seen in my career - but as I went through the lung I realized the reason why there was pneumonia. 'It was because there was a cancerous tumor, a small cell carcinoma of the lung that was encasing the airway,' he explained. 'So what happens is it grows into the airway and closes the airway off and causes a pneumonia behind that, it's called the post obstructive pneumonia secondary to malignancy.' He added that pneumonia is not the cause of death, but the 'end point' of the actual underlying cause, which is cancer. 'Without the cancerous tumor blocking the airway, you wouldn't have had the pneumonia,' Dr. Wolfe explained. The doctor then listed another example with a younger patient, who was a man in his early 20s. '[He had] had several months of abdominal pain, weight loss and fevers, also night sweats, and he refused to go to the doctor to investigate this.' 'Then the pain became so intense that he finally did go to the ER and they thought it was going to be some kind of appendicitis or ruptured organ,' the medical professional continued. Sadly, the young man didn't even make it to the CT scanner before he passed away. 'He wasn't able to be revived,' he somberly recalled. When the man was taken to Dr. Wolfe to perform an autopsy, he found him riddled with cancer. 'I opened him up and found cancer in essentially every organ from his clavicles to his pelvis, also in the abdominal wall and the omentum [tissue that drapes over the intestines],' he recalled. The doctor said it was a non-Hodgkin's lymphoma case, explaining: 'The tumor burden just gets so high it messes up the electrolytes for the patient and then they develop cardiac arrhythmia.' The last patient was a 65-year-old man who had colon cancer symptoms, but passed away before he could have a colonoscopy. 'I [did] the autopsy to determine the cause of death and it turns out he did actually have stage four colon cancer that was metastatic widely throughout his abdomen, and also into his lungs and had basically grown through the wall of the colon,' he shared. As per Healthline, there is no definitive length of time someone can have cancer without knowing it, explaining that some cancers can be present for months or years before they're detected. According to a 1990 report from the National Library of Medicine, 11 percent of patients over a 25-year period died from cancer without it being diagnosed. As per the report, over 20,000 autopsies were carried out over a 25-year period, with 700 cancers (11 percent) were found in patients in whom the diagnosis of cancer had not been considered relevant clinically. Doctors always recommend regularly visiting a doctor for health screenings.
Medical News Today
an hour ago
- Medical News Today
How Tremfya works: Mechanism of action explained
How it works How long it takes to work Tremfya (guselkumab) is a prescription drug that treats psoriatic arthritis, plaque psoriasis, and ulcerative colitis. Its mechanism of action is binding to interleukin-23 that's overactive. Tremfya belongs to a class of medications called interleukin-23 blockers. It's a type of biologic called a monoclonal antibody, which is a protein that attaches to substances in the body. Tremfya works by binding to interleukin-23 (a protein in the body) that's overactive. By binding to this protein, Tremfya decreases how active your immune system is to ease inflammation and decrease symptoms of your condition. The way a drug works is known medically as its mechanism of action. The mechanism of action for Tremfya may vary depending on the condition it's being used to treat. Tremfya is approved by the Food and Drug Administration (FDA) to treat certain conditions, including psoriatic arthritis. When you have psoriatic arthritis, your immune system (your body's defense against infections) is overactive. It attacks healthy tissues and cells, causing joint pain and inflammation. It also causes your body to make too many skin cells, leading to a buildup of cells and areas called plaques. These plaques are flushed, itchy patches on your skin. Tremfya is FDA-approved to treat moderate to severe plaque psoriasis. This condition is one of many types of psoriasis. When you have plaque psoriasis, your immune system is overactive. It causes your body to make too many skin cells, leading to a buildup of cells and areas called plaques. These plaques are itchy patches on your skin. They may look pink or be darker than your skin color. Sometimes, they may look white and scaly. Tremfya may be an option for plaque psoriasis treatment if you can receive either: systemic therapy (treatment that affects your whole body), or phototherapy (treatment with light) Tremfya is FDA approved to treat moderate to severely active ulcerative colitis (UC) in adults. When UC is active, it's causing symptoms. Tremfya is prescribed to help put UC in remission and keep it there. With remission, you have few or no symptoms of the condition. Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the colon and rectum. It's thought to result from overactivity in a person's immune system. With UC, you have inflammation in your colon, rectum, or both. In severe cases, ulcers can also form in these areas. Symptoms of this condition include blood in your stool, diarrhea, abdominal pain or cramps, and weight loss. For this condition, Tremfya is typically prescribed alone. Your doctor may also prescribe nonbiologics to treat an ulcerative colitis flare-up. Tremfya is FDA approved to treat Crohn's disease. Like UC, Crohn's disease is a type of IBD. Unlike UC, which affects the colon and rectum, Crohn's disease can affect your entire digestive system, including your stomach, intestines, and colon. To find out more about Crohn's disease, visit our IBD hub. In clinical trials, people with plaque psoriasis often experienced a reduction in symptoms after receiving three doses of Tremfya over 16 weeks. Also, more than half of the people receiving Tremfya for psoriatic arthritis in clinical trials experienced a decrease in symptoms after 16 weeks of treatment. In a clinical trial of Tremfya for UC, more than half of the people receiving the drug experienced a decrease in symptoms after 12 weeks. Some people also experienced remission (few or no symptoms of UC). If you have more questions about how long it takes for Tremfya to work, talk with your doctor or pharmacist. Disclaimer: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses. Medical News Today has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical journals and associations. We only use quality, credible sources to ensure content accuracy and integrity. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.
